$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
【患者关注】泊马度胺在中国上市了吗?多少钱一盒?
2025-10-19 11:44:20
Check Details
【用药早知道】塞利尼索是什么药?治疗什么病症?
2025-10-19 11:44:20
Check Details
马法兰单一化疗及联合化疗中为多发性骨髓瘤的首选药
2025-10-19 11:44:20
Check Details
塞利尼索可有效改善多发性骨髓瘤患者的生存期
2025-10-19 11:44:20
Check Details
马法兰治疗多发性骨髓瘤的效果数据
2025-10-19 11:44:20
Check Details
服用泊马度胺时需要吃多少剂量的地塞米松?
2025-10-19 11:44:20
Check Details
多发性骨髓瘤有什么症状?多发性骨髓瘤怎么治疗?塞利尼索可以吗?
2025-10-19 11:44:20
Check Details
帕比司他联合硼替佐米治疗多发性骨髓瘤效果如何?用法用量是多少?
2025-10-19 11:44:20
Check Details
马法兰2021年在国内纳入国家医保了吗?
2025-10-19 11:44:20
Check Details
难治或复发性多发性骨髓瘤怎么治疗?看完你就明白了
2025-10-19 11:44:20
Check Details
泊马度胺一个疗程几天?一个疗程多少钱?
2025-10-19 11:44:20
Check Details
塞利尼索联合地塞米松对多发性骨髓瘤有着明显的疗效
2025-10-19 11:44:20
Check Details
1
2
...
1142
1143
1144
1145
1146
1147
1148
...
4163
4164
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Binimetinib + Encorafenib: Dual MEK/BRAF Targeting in BRAF+ Tumors
2
Neratinib Dosing: 240mg Start, Diarrhea Prophylaxis, Hepatic Adjustment
3
Selumetinib and KRAS Mutations: Where the MEK Inhibitor Actually Fits
4
Erdafitinib in Lung Squamous Cell Carcinoma: Indication Boundaries and FGFR Interpretation
5
Daraxonrasib (Rasonque): Chemical Identity and RAS Tri-Complex Mechanism
6
Tamoxifen and Feeling Older: Managing Hot Flashes, Fatigue, and Skin Changes
7
FDA Approves Pembrolizumab for TMB-H Solid Tumors: Threshold ≥13 mut/Mb, KEYNOTE-158 Data
8
Capmatinib for METex14 NSCLC: Test First, Monitor Toxicity
9
Ribociclib Still Allows Recurrence: HR+/HER2- Adjuvant and Advanced Use
10
Tucatinib HER2 TKI: With Trastuzumab + Capecitabine, Diarrhea and Hepatotoxicity Monitoring
11
Pemigatinib for FGFR2-Rearranged Cholangiocarcinoma: Eligibility, Response Limits, Hyperphosphatemia and Ocular Monitoring
12
Cabozantinib with Aspirin: Additive Bleeding Risk, Do Not Stop Cardiac Aspirin Alone, Urgent Warning Signs